Hong Kong-headquartered Tiger Cub hedge fund Karst Peak Capital’s Sydney-based healthcare partner Hashan De Silva is starting his own fund, according to a report by the Financial Review. De Silva’s firm will launch with seed capital from Karst Peak Capital founder Adam Leitzes, who formerly worked at Julian Robertson’s Tiger Management.
The new VC-style healthcare fund – dubbed dubbed KP RX – will reportedly invest in Australian and New Zealand healthcare companies.
De Silva was Hong Kong-based Karst Peak’s first Australian hire in early 2021. He joined from joining from sell-side research at CLSA and Macquarie. The healthcare specialist’s buy-side stockpicks included regenerative medicine business Avita Medical and neurological drug developer Neuren Pharmaceuticals, which have risen 125% and 235%, respectively, over the past year.
